NKTR
NASDAQ · Pharmaceuticals
Nektar Therapeutics
$70.67
-0.78 (-1.09%)
Open$70.84
Previous Close$71.45
Day High$71.43
Day Low$69.50
52W High$109.00
52W Low$21.60
Volume—
Avg Volume683.9K
Market Cap2.52B
P/E Ratio—
EPS$-8.32
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
-40.2% upside
Current
$70.67
$70.67
Target
$42.23
$42.23
$31.85
$42.23 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 116.65M | 138.33M | 246.52M |
| Net Income | -346,529,860 | -369,829,092 | 56.66M |
| Profit Margin | -297.1% | -282.2% | 23.0% |
| EBITDA | -293,727,651 | -330,892,053 | 106.98M |
| Free Cash Flow | — | — | 45.61M |
| Rev Growth | -15.7% | -15.7% | +15.2% |
| Debt/Equity | 0.70 | 0.70 | 0.88 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |